20 Old Brompton Road, South Kensington, London SW7 3DL
20 Old Brompton Road, South Kensington, London SW7 3DL
| CODE | TEST | TAT | PRICE |
|---|---|---|---|
| 10A | Allergy Profile 10 (Insects) | 2 days | 212 |
| 10AL | Allergy – 10 x Single Individual Allergens | 2 days | 350 |
| 10RF | HLA DQ Alpha Antigens | 2 weeks | 220 |
| 11A | Allergy Profile 11 (Combined Shellfish/Finfish) | 2 days | 239 |
| 11RF | HLA DQ Beta Antigens | 2 weeks | 220 |
| 12A | Allergy Profile 12 (Milk & Milk Proteins) | 2 days | 263 |
| 13A | Allergy Profile 13 (Stone fruit/Rosaceae family) | 2 days | 263 |
| 14RF | HLA A, B, C | 2 weeks | 337 |
| 16RF | NK Assay Panel + Intralipids | 1 week | 708 |
| 17OH | 17 Hydroxyprogesterone | 5 days | 137 |
| 17RF | KIR (Killer-like Immunoglobulin-like Receptors) Genotyping | 2-3 weeks | 446 |
| 1A | Allergy Profile 1 (Food & Inhalants) | 2 days | 665 |
| 1TH2 | TH1/TH2 Cytokine Profile | Send Mon-Thurs only | 430 |
| 20RF | TH1/TH2 Intracellular Cytokine Ratios with IVIG, Prednisolone | 1 week | 934 |
| 21RF | TH1/TH2 Intracellular Cytokine Ratios with IVIG | 1 week | 748 |
| 22RF | TH1/TH2 Intracellular Cytokine Ratios with Prednisolone | 1 week | 748 |
| 25RF | T Regulatory Cells | 3 days | 691 |
| 26RF | HLA-C | 2 weeks | 220 |
| 2A | Allergy Profile 2 (UK Aero Allergen) | 2 days | 366 |
| 2C19 | Cytochrome P450 2C19 | 10 days | 543 |
| 3A | Allergy Profile 3 (Food) | 2 days | 332 |
| 3RF | Reproductive Immunophenotype Panel | 1 week | 482 |
| 4A | Allergy Profile 4 (Nuts & Seeds) | 2 days | 470 |
| 4RF | NK Assay/Cytotoxicity Panel | 1 week | 569 |
| 5A | Allergy Profile 5 (Children’s Panel) | 2 days | 332 |
| 5AL | Allergy – 5 x Single Individual Allergens | 2 days | 181 |
| 5FU | Dihydropyrimidine Dehydrogenase deficiency screening (Fluoropyrimidine Toxicity) | 1-2 weeks | 430 |
| 5NT | 5’ Nucleotidase | 5 days | 98 |
| 5RF | NK Assay Follow-Up Panel | 1 week | 482 |
| 69C | NK (CD69) and NK Cytotoxicity | Send Mon-Thurs only | 900 |
| 69CI | NK Cytotoxicity with suppression with steroid, IVIg and intralipin, and NK (CD69) cell assay | Send Mon-Thurs only | 1058 |
| 6A | Allergy Profile 6 (Shellfish) | 2 days | 298 |
| 6RF | TH1/TH2 Cytokine Ratio | 1 week | 446 |
| 7A | Allergy Profile 7 (Finfish) | 2 days | 298 |
| 8A | Allergy Profile 8 (Cereal – singles) | 2 days | 174 |
| 8RF | Leucocyte Antibody Detection Panel FEMALE | 1 week | 271 |
| 9A | Allergy Profile 9 (Antibiotics) | 2 days | 136 |
| 9RF | HLA DR Antigens | 2 weeks | 271 |
| A1AF | Alpha-1-Antitrypsin (Stool) | 10 days | 106 |
| A1AT | Alpha-1-Antitrypsin (Serum) | 1 day | 139 |
| A1MG | Alpha-1-Microglobulin | 10 days | 100 |
| A2MG | Alpha-2-Macroglobulins | 5 days | 133 |
| AA2R | Anti-Phospholipase A2 Receptor | 6 weeks | 121 |
| AAA | Anti-Actin Antibodies | 5 days | 100 |
| AASC | Atypical Antibody Screen (handwritten tube label) | 2 days | 67 |
| ABGA | Anti-Basal Ganglia Antibodies | 3 weeks | 503 |
| ABO | Blood Group † | 2 days | 74 |
| ACAB | Cardiolipin Antibodies (IgG+IgM) | 2 days | 94 |
| ACE | Angiotensin Converting Enzyme | 1 day | 103 |
| ACRA | Acetylcholine Receptor Autoantibodies | 5 days | 257 |
| ACTB | Acetone – Blood | 6 weeks | 133 |
| ACTU | Acetone – Urine | 5 days | 133 |
| ACTX | Adrenal Cortex Antibodies | 2 days | 75 |
| AD | Adenosine Deaminase | 3 weeks | 345 |
| ADIP | Adiponectin | 2 weeks | 274 |
| ADV | Adenovirus by PCR | 7 days | 323 |
| AFAT | Amoebic (E. histolytica) Antibodies | 1 week | 62 |
| AFP | Alpha-Fetoprotein | 1 day | 68 |
| AGAB | Gliadin Antibodies (IgG) (deamidated) (Venous) | 2 days | 113 |
| AGBM | Glomerular Basement Membrane Abs | 2 days | 88 |
| AHSC | Acute Viral Hepatitis Screen | 1 day | 211 |
| AHT | Hyaluronic Acid | 1 week | 84 |
| ALB | Albumin | 1 day | 35 |
| ALCA | Anti-Liver Cytosol Antibodies | 5 days | 91 |
| ALCO | Alcohol (Medical) | 1 day | 97 |
| ALCP | Alcohol Profile 2 | 5-7 days | 311 |
| ALDN | Aldosterone | 5 days | 158 |
| ALDO | Aldolase | 5 days | 71 |
| ALEC | Atopic Dermatitis/Eczema Profile (14 allergens) | 2 days | 380 |
| ALEX | ALEX² Allergy Test (Venous) | 3-4 days | 380 |
| ALLE | Allergy – Individual Allergens | 2 days | 48 |
| ALP | Alkaline Phosphatase | 1 day | 35 |
| ALRN | Allergic Rhinitis/Asthma Profile | 2 days | 355 |
| ALRP | Leukaemia (Rapid Acute) DNA and RNA NGS Panel . Requires patient informed consent | 3 days | 824 |
| ALT | ALT (Alanine Aminotransferase) (SGPT) | 1 day | 35 |
| ALUM | Aluminium (Blood) | 7 days | 91 |
| ALUU | Aluminium (Urine) | 1-2 weeks | 123 |
| AMAG | Amoebic (E. histolytica) PCR | 2 days | 63 |
| AMEN | Amenorrhoea Profile (Venous) | 1 day | 172 |
| AMH | Antimullerian Hormone (AMH) (Venous) | 1 day | 150 |
| AMIK | Amikacin Level (State dose) | 1 day | 139 |
| AMIT | Mitochondrial Antibodies | 3 days | 62 |
| AMOG | Anti-MOG [Myelin Oligodendrocyte Glycoprotein] Antibodies | 3 weeks | 147 |
| AMPB | Amphetamines – Blood | 5 days | 104 |
| AMTR | Amitriptyline | 5 days | 132 |
| AMY | Amylase (Venous) | 1 day | 59 |
| AMYI | Amylase lsoenzymes | 5 days | 221 |
| ANAB | Anti-Nuclear Antibodies (titre & pattern) | 2 days | 63 |
| ANAE | Anaemia Profile | 2 days | 200 |
| ANCA | ANCA (Anti-Neutrophil Cytoplasmic Abs) | 2 days | 133 |
| ANDG | Androstanediol Glucuronide | 3 weeks | 167 |
| ANDP | Andropause Profile | 1 day | 212 |
| ANDR | Androstenedione | 5 days | 108 |
| ANTE | Antenatal Profile | 3 days | 676 |
| ANTI | Antimony (Urine) | 10 days | 121 |
| AP | Alcohol Profile | 5-7 days | 230 |
| APEG | Apolipoprotein E genotype – E2/E3/E4 | 2 weeks | 270 |
| APIE | Alkaline Phosphatase lsoenzymes | 5 days | 139 |
| APOA | Apolipoprotein A1 (Venous) | 3 days | 87 |
| APOB | Apolipoprotein B (Venous) | 3 days | 87 |
| APOC | Apolipoprotein C | 3 months | 104 |
| APOE | Apolipoprotein E (12 hours fasting) | 5 days | 106 |
| APS | Atypical Pneumonia Screen | 3 days | 160 |
| APS | Pneumonia (Atypical) Screen | 3 days | 160 |
| APT | Acid Phosphatase – Total | 5 days | 60 |
| APT | Total Acid Phosphatase | 5 days | 60 |
| AQUA | Aquaporin 4 Antibodies (Neuromyelitis Optica) | 2 weeks | 317 |
| ARBO | Arbovirus Antibodies/Abs | 3 weeks | 221 |
| ARS | Arsenic (Blood) | 5 days | 96 |
| ARSE | Arsenic (Urine) | 5 days | 96 |
| ARYL | Arylsulphatase A | 8 weeks | 374 |
| ASA | Anti-Sulfatide Antibodies | 5 weeks | 295 |
| ASAB | Sperm Antibodies (Serum) | 5 days | 159 |
| ASC | Ascariasis Serology | 5 days | 100 |
| ASCA | Saccharomyces Cerevisiae Antibodies | 2 weeks | 159 |
| ASLT | Anti-Streptolysin Titre/ASOT | 2 days | 68 |
| ASMO | Smooth Muscle Antibodies | 2 days | 62 |
| ASPP | Aspergillus Precipitins | 5 days | 147 |
| AST | Aspartate Transaminase (AST) (SGOT) | 1 day | 35 |
| ASTT | Anti-Staphylolysin Titre (SGOT) | 3 days | 66 |
| AUTO | Autoantibody Profile I | 2 days | 174 |
| AVIA | Avian Precipitins (11 Species) | 5 days | 424 |
| B12 | Vitamin B12 (Active) (Venous) | 1 day | 81 |
| B12F | Vitamin B12 (Active)/Red Cell Folate | 2 days | 128 |
| B2GP | Beta 2 Glycoprotein 1 Abs | 2 days | 142 |
| B2MG | Beta 2 Microglobulin (Serum) | 2 days | 111 |
| B51 | Behcet’s Disease – HLA Tissue Typing B*51 | 10 days | 276 |
| B51 | HLA Tissue Typing B*51 (Behcet’s Disease) | 10 days | 276 |
| BCRD | BCR-ABL Diagnostic Assay | 2 weeks | 451 |
| BCRQ | BCR/ABL Quantitative – fusion gene sizes p190 + p210 | 10 days | 422 |
| BCUL | Blood Culture# | 6 days + | 114 |
| BGLU | Beta-Glucuronidase (Sly Disease) | 8 weeks | 317 |
| BILE | Bile Acids – Serum | 1 day | 76 |
| BILH | Bilharzia (Schistosome) Antibody Screen | 10 days | 133 |
| BILH | Schistosome (Bilharzia) Antibodies | 10 days | 133 |
| BILI | Bilirubin (Total) | 1 day | 35 |
| BILS | Total Bile Acid/Bile Salts | 1 week | 97 |
| BIOS | Biotin | 5 days | 177 |
| BIOS | Vitamin B7 (Biotin) | 5 days | 177 |
| BISM | Bismuth | 5 days | 185 |
| BKPV | BK Polyoma Virus by PCR | 5 days | 271 |
| BNP | BNP (NT-pro BNP) | 1 day | 108 |
| BON2 | Bone Screen (Bloods only) | 1 day | 148 |
| BONE | Bone Screen | 1 day | 64 |
| BORC | Borrelia Confirmation (Immunoblot) | 10 days | 403 |
| BORM | Borrelia Antibodies (Lyme Disease) IgM | 2 days | 84 |
| BORM | Lyme Disease (Borrelia Abs) IgM | 2 days | 84 |
| BORR | Borrelia Antibodies (Lyme Disease) IgG, IgM | 2 days | 108 |
| BORR | Lyme Disease (Borrelia Abs) IgG, IgM | 2 days | 108 |
| BPCR | Blood PCR for Chromosome 13, 18, 21 and sex chromosomes | 5 days | 307 |
| BROM | Bromide | 3 days | 170 |
| BRUC | Brucella Serology | 2-3 weeks | 113 |
| BUN | BUN (Blood Urea Nitrogen) (Calculated) | 1 day | 38 |
| BUTA | 2-Butanone GC | 7 days | 177 |
| C125 | CA 125 (Venous) | 1 day | 146 |
| C153 | CA 15-3 | 1 day | 146 |
| C199 | CA 19-9 | 1 day | 146 |
| C1EI | C1 Esterase Inhibitor | 5 days | 106 |
| C1Q | Complement C1q | 5 days | 87 |
| C2 | Complement C2 | 10 days | 198 |
| C3 | C3 Complement | 1 day | 63 |
| C3 | Complement C3 | 1 day | 63 |
| C4 | C4 Complement | 1 day | 63 |
| C4 | Complement C4 | 1 day | 63 |
| C5A | Complement C5 | 2 weeks | 198 |
| C724 | CA 72-4 | 5 days | 156 |
| CA | Calcium (Venous) | 1 day | 35 |
| CA2A | Colloid Antigen-2 Antibodies | 2 weeks | 142 |
| CA50 | CA 50 | 5 days | 181 |
| CACR | Calcium/Creatinine Ratio | 1 day | 66 |
| CADM | Cadmium (Blood) | 5 days | 96 |
| CALD | Calcium + Vitamin D (Venous) | 1 day | 122 |
| CALP | Calprotectin | 5 days | 111 |
| CALP | Calprotectin (Self-collect) | 5 days | 111 |
| CANA | Candida Antibodies | 5 days | 137 |
| CANC | Candida (Culture for ID Only) | 2-4 days | 93 |
| CAND | Candida (Culture for ID + Sensitivities) | 2-4 days | 93 |
| CANN | Cannabinoids (Urine) Screen | 1 day | 63 |
| CANS | Candida auris Screen | 2-4 days | 118 |
| CARB | Carbamazepine (Tegretol) | 1 day | 75 |
| CARB | Tegretol (Carbamazepine) | 1 day | 75 |
| CARO | Beta Carotene | 5 days | 159 |
| CARO | Carotenes | 5 days | 159 |
| CAT | Cat Scratch Fever (Bartonella IgG) | 5 days | 239 |
| CATF | Fluid Cytology | 3 days | 186 |
| CBHB | Carboxyhaemoglobin | 1 week | 96 |
| CCAB | Voltage Gated Calcium Channel Antibodies | 3 weeks | 309 |
| CCP | Anti-CCP Antibodies | 2 days | 62 |
| CCP | CCP Antibodies (RF) | 2 days | 62 |
| CD16 | CD16 | 1 day | 142 |
| CD19 | CD19 B Cells | 1 day | 142 |
| CD20 | CD20 | 2 days | 155 |
| CD25 | CD25 | 2 days | 104 |
| CD56 | CD56 | 1 day | 100 |
| CD57 | CD57 | 1 day | 137 |
| CD69 | NK (CD69) Cell Assay | Send Mon-Thurs only | 324 |
| CDG | Carbohydrate Deficient Glycoprotein | 2 weeks | 337 |
| CDT | Carbohydrate Deficient Transferrin (CDT) (Venous) | 3 days | 185 |
| CEA | Carcino Embryonic Antigen | 1 day | 91 |
| CERS | Swab (Cervical) | 2-4 days | 93 |
| CERU | Caeruloplasmin | 1 day | 66 |
| CFS | Cystic Fibrosis (139 common variants) – reflex to Poly T when required | 5-7 days | 378 |
| CGA | Chromogranin A | 1 week | 188 |
| CGEN | Hepatitis C Genotype | 5 days | 658 |
| CGH | Postnatal SNP Array CGH | 10 days | 945 |
| CHGA | Chagas Disease Serology (S.American Trypanosomiasis) T. Cruzi | 10 days | 173 |
| CHGA | Trypanosome (Chagas) Antibodies | 10 days | 173 |
| CHIK | Chikungunya Virus Abs | 10 days | 221 |
| CHLO | Anafranil (Clomipramine) | 7 days | 139 |
| CHLO | Clomipramine (Anafranil) | 7 days | 139 |
| CHO | Cholesterol | 1 day | 32 |
| CHPS | Cholinesterase (Serum/Pseudo) | 1 day | 64 |
| CHRO | Chromium (Blood) | 5 days | 84 |
| CITR | Citrate (Blood) | 5 days | 103 |
| CJAB | Campylobacter Jejuni Antibodies | 5 days | 93 |
| CKIE | CK Isoenzymes | 5 days | 139 |
| CKMB | CK (MB Fraction) | 1 day | 58 |
| CKNA | Creatine Kinase (CK, CPK) | 1 day | 41 |
| CL | Chloride | 1 day | 29 |
| CLOB | Clobazam | 5 days | 139 |
| CLON | Clonazepam | 7 days | 125 |
| CLOS | Clostridium Difficile Toxin by PCR | 2 days | 118 |
| CLOT | Coagulation Profile 2 | 1 day | 125 |
| CLPF | Coagulation Profile 1 | 1 day | 96 |
| CMAV | Cytomegalovirus Avidity | 10 days | 150 |
| CMV | Cytomegalovirus (IgG/IgM) Antibodies | 1 day | 97 |
| CMVM | CMV IgM Antibodies | 1 day | 156 |
| CMVP | Cytomegalovirus DNA (PCR) | 5 days | 300 |
| CMVR | Cytomegalovirus Resistance | 21 days | 757 |
| CMVU | Cytomegalovirus (PCR) Urine | 5 days | 300 |
| COB | Cobalt (Blood) | 5 days | 96 |
| COBA | Cobalt (Urine) | 5 days | 96 |
| COMP | C3/C4 Complement | 1 day | 104 |
| COOM | Coombs (Direct Antiglobulin Test) | 2 days | 40 |
| COPP | Copper (Serum) | 5 days | 71 |
| CORT | Cortisol (Venous) | 1 day | 66 |
| COT | Cotinine (Serum) | 4 days | 110 |
| COTT | Cotinine (Urine) | 2 days | 83 |
| CPEP | C Peptide | 3 days | 154 |
| CPP | Chest Pain Profile | STAT | 158 |
| CPSA | Complex PSA (Prostate Specific Ag) | 3 days | 91 |
| CQ10 | Coenzyme Q10 | 2 weeks | 188 |
| CRCL | Creatinine Clearance | 1 day | 63 |
| CREA | Creatinine (including eGFR) (Venous) | 1 day | 35 |
| CRP | C Reactive Protein (Venous) | 1 day | 62 |
| CRPA | Cryptosporidium Detection by PCR | 2 days | 93 |
| CURT | Histamine Releasing Urticaria Test | 3 weeks | 196 |
| CURT | Urticaria Test (Histamine Releasing) | 3 weeks | 196 |
| CY21 | Cyfra 21-1 | 4 days | 228 |
| CYCC | Cystatin C | 5 days | 120 |
| CYCL | Cyclosporin | 1 day | 155 |
| D3 | 1,25 Vitamin D | 5-8 days | 171 |
| D3 | Vitamin D (1, 25 Dihydroxy) | 5-8 days | 171 |
| DBIL | Bilirubin (Direct) | 1 day | 35 |
| DDIT | D-Dimers (Fibrinogen Degradation Products) | 1 day | 83 |
| DENG | Dengue Virus Serology | 5 days | 142 |
| DEOX | 11 Deoxycorticosterone | 10 days | 147 |
| DERM | Fungal investigations (superficial/dermatophyte PCR test) | 3-7 days | 93 |
| DERM | Skin Scrapings/Mycology by PCR | 3-7 days | 93 |
| DHEA | DHEA Sulphate (Venous) | 1 day | 96 |
| DHEX | DHEA | 7-10 days | 163 |
| DHT | Dihydrotestosterone | 7 days | 155 |
| DIA2 | Diabetic Profile 2 | 2 days | 142 |
| DIAB | Diabetic Profile 1 | 1 day | 74 |
| DIAM | Diamine Oxidase Activity | 2 weeks | 113 |
| DIAZ | Diazepam (Valium) | 7 days | 125 |
| DIAZ | Valium (Diazepam) | 7 days | 125 |
| DIGO | Digoxin | 1 day | 103 |
| DIPH | Diphtheria Antibodies | 5 days | 100 |
| DL1 | DL1 Biochemistry Profile | 1 day | 57 |
| DL10 | Cardiovascular Risk Profile 1 | 3 days | 416 |
| DL10 | Screening Profile 10 – Cardiovascular Risk 1 | 3 days | 416 |
| DL11 | Cardiovascular Risk Profile 2 | 3 days | 502 |
| DL11 | Screening Profile 11 – Cardiovascular Risk 2 | 3 days | 502 |
| DL1L | DL1L Biochemistry Profile plus HDL Cholesterol, LDL Cholesterol and Non-HDL Cholesterol | 1 day | 63 |
| DL2 | DL2 Biochemistry (24 Parameters) & Haematology Profile | 1 day | 74 |
| DL3 | DL3 Haematology Profile | 1 day | 36 |
| DL4 | DL4 Biochemistry (16 Parameters) & Haematology Profile | 1 day | 68 |
| DL5L | Screening Profile 5 – Haematology/Biochemistry (Postal) | 1 day | 202 |
| DL6 | DL6 General Well Person Profile | 1 day | 149 |
| DL7 | DL7 Well Man Profile | 1 day | 183 |
| DL7L | DL7L Well Man Profile plus HDL Cholesterol, LDL Cholesterol and Non-HDL Cholesterol | 1 day | 189 |
| DL8 | DL8 Well Person Profile | 1 day | 183 |
| DL8L | DL8L Well Person Profile plus HDL Cholesterol, LDL Cholesterol and Non-HDL Cholesterol | 1 day | 189 |
| DL9F | Screening Profile 9F – Senior Female | 2 days | 613 |
| DL9M | Screening Profile 9M – Senior Male | 2 days | 641 |
| DMD1 | Becker/Duchenne Muscular Dystrophy – deletions/duplications | 10 days | 827 |
| DMD1 | Duchenne Muscular Dystrophy – deletions/duplications only | 10 days | 827 |
| DNA | Nucleic Acid Antigen Antibodies | 2 days | 91 |
| DNAA | DNA (Double Stranded) Antibodies IgG | 2 days | 75 |
| DNAC | Zygosity Testing – comparative DNA profile | 5 days | 765 |
| DNAF | DNA Identity Profile – 15 STR markers | 10 days | 458 |
| DNAF | Identity Profile (DNA) – 15 STR markers | 10 days | 458 |
| DNAS | DNA (Single Stranded) Antibodies | 5 days | 84 |
| DOXE | Doxepin Level (Sinequan) | 10 days | 139 |
| DOXE | Sinequan (Doxepin) | 10 days | 139 |
| DPCR | Dengue Fever PCR | 2 weeks | 328 |
| DPD | Deoxypyridinoline (DPD) – Urine | 4 days | 123 |
| DPRO | Propoxyphene | 5 days | 132 |
| DRB1 | HLA Tissue Typing DRB1/3/4/5 | 10 days | 276 |
| DRNA | Hepatitis Delta RNA | 5 days | 329 |
| DUST | Phencyclidine (PCP) | 5 days | 94 |
| DVT1 | DVT/Pre-travel Screen | 5 days | 329 |
| DVT1 | Pre-Travel Screen (DVT) | 5 days | 329 |
| E1 | Oestrone | 4 days | 123 |
| E3 | Oestriol (Estriol) | 4 days | 123 |
| EARS | Swab (Ear) | 2-4 days (Culture) 8-9 days (Fungal) – same swab | 93 |
| EBVA | Epstein-Barr Virus Antibodies IgG/IgM | 2 days | 182 |
| EBVQ | Epstein-Barr Virus PCR | 5 days | 177 |
| ECP | Eosinophil Cationic Protein | 7 days | 151 |
| EFAR | Essential Fatty Acid Profile (Red Cell) | 10 days | 223 |
| EFAT | Echinococcus (Hydatid) Antibodies | 5 days | 82 |
| EHEP | Hepatitis E RNA (PCR) | 2 weeks | 263 |
| EHRL | Ehrlichiosis Antibodies | 10 days | 137 |
| ELAS | Elastase (RF) | 5 days | 128 |
| ELAS | Elastase (Self-collect) | 5 days | 128 |
| ELEC | Electrolytes | 1 day | 41 |
| ELF | ELF/Enhanced Liver Fibrosis | 5 days | 234 |
| ELF | Liver Fibrosis (Enhanced Liver Fibrosis ELF) | 5 days | 234 |
| EMA | Eosin-5 Maleimide Dye binding test for Hereditary spherocytosis (EMA)* | 2 days | 190 |
| ENA | Extractable Nuclear Antibodies (nRNP, Sm, Ro, La, Jo1, Scl70) CENP-B | 2 days | 87 |
| ENDO | Autoantibody Profile II | 3 days | 165 |
| ENDT | Ziwig Endotest® | 25 days | 977 |
| EORD | Enteric Organism Rapid Detection (RF) | 2 days | 257 |
| EORD | Enteric Organism Rapid Detection (Self-collect) | 2 days | 257 |
| EORD | Gastrointestinal Pathogen Profile by PCR (Self-collect) | 2 days | 257 |
| ERY | Erythropoietin | 4 days | 105 |
| ESR | ESR | 1 day | 38 |
| ETG | Urine EtG (Ethyl glucuronide) | 1 week | 129 |
| ETHO | Ethosuximide | 7 days | 88 |
| EYES | Swab (Eye) | 2-4 days | 93 |
| F8IA | Factor VIII Inhibiting Antibody | 2 weeks | 147 |
| F9IA | Factor IX Inhibiting Antibody | 2 weeks | 147 |
| FACH | Complement Factor H | 3 weeks | 194 |
| FARM | Farmers Lung Precipitins | 5 days | 131 |
| FASC | Fasciola Hepatica Antibodies (Liver Fluke) | 2 weeks | 166 |
| FBC | Full Blood Count | 1 day | 56 |
| FCG | FAST CT/GC – Urine | 1 day | 124 |
| FE | Iron (TIBC included) (Venous) | 1 day | 38 |
| FERR | Ferritin (Venous) | 1 day | 96 |
| FFAT | Faecal Fat (3 day) | 5 days | 150 |
| FIB | Fibrinogen | 1 day | 51 |
| FIBT | Fibrotest (Liver Fibrosis) | 2 weeks | 329 |
| FIBT | Liver Fibrosis Fibrotest | 2 weeks | 329 |
| FIFA | Filaria (Lymphatic and Non-Lymphatic) Antibodies | 10 days | 132 |
| FILM | Blood Film Examination | 1 day | 41 |
| FIP | Female Hormone Profile (Venous) | 1 day | 172 |
| FIRI | Fasting Insulin Resistance Index (FIRI) | 1 day | 98 |
| FK5 | FK506 (Tacrolimus/Prograf) | 1-2 days | 160 |
| FK5 | Tacrolimus/Prograf (FK506) | 1-2 days | 160 |
| FLAC | Faecal Lactoferrin | 5 days | 100 |
| FLEA | Insect/Worm/Ova/Cysts | 5 days | 120 |
| FLEC | Flecainide (Tambocor) | 5 days | 147 |
| FLT3 | FLT3-ITD and FLT3-TKD screening assay | 24 hours | 524 |
| FLU2 | Synovial Fluid (for microscopy, crystals and culture) | 14 days | 156 |
| FLU4 | Respiratory PCR Panel (COVID-19, Flu A/B and RSV) (PCR) | 2 days | 269 |
| FLU4 | Respiratory PCR Panel (COVID-19, Flu A/B and RSV) (Self-collect) | 2 days | 269 |
| FLUD | Fluid Culture | 2-7 days | 132 |
| FLUP | Pleural Fluid for Culture | 7 days | 132 |
| FOLA | Folate (Serum) | 1 day | 60 |
| FOLA | Vitamin B9 (Folic acid) – Serum | 1 day | 60 |
| FOS | Trimethylaminuria (Fish Odour Syndrome) | 6 weeks | 447 |
| FPOR | Porphyrin (Stool) | 3 weeks | 151 |
| FRCG | FAST CT/GC – Rectal PCR Swab | 1 day | 124 |
| FRUC | Fructosamine | 1 day | 55 |
| FSH | FSH (Venous) | 1 day | 63 |
| FSSC | FAST Screen SHORT with Urine | 1 day | 173 |
| FSSS | FAST Screen SHORT with Swab | 1 day | 173 |
| FSWS | FAST Screen with Swab | 1 day | 319 |
| FT3 | Free T3 (Venous) | 1 day | 63 |
| FT4 | Free T4 (Venous) | 1 day | 63 |
| FTCG | FAST CT/GC – Throat PCR Swab | 1 day | 124 |
| FTES | Testosterone (Free) (Venous) | 3 days | 129 |
| FTMS | First Trimester Maternal Screen (PAPP-A/Free Beta-hCG) | 1 day | 104 |
| FUN | Fungal investigations (non-superficial extended culture) | 3-21 days | 93 |
| FUNC | Vitamin B (Functional) | 5 days | 170 |
| FUSC | FAST Screen with Urine | 1 day | 319 |
| FVWF | Von Willebrand Profile | 5 days | 263 |
| FX2 | Factor II Prothrombin – G20210A Variant | 5 days | 248 |
| FX5 | Factor V Leiden – G1691A Variant | 5 days | 248 |
| G6PD | G6PD | 4 days | 116 |
| GABA | Gabapentin | 5 days | 117 |
| GACA | Ganglionic Acetylcholine Receptor Antibodies | 9 weeks | 136 |
| GAD | Glutamic Acid Decarboxylase Antibodies (GAD 65) | 5 days | 185 |
| GAL1 | Galactose-1-Phosphate Uridyltransferase | 2 weeks | 296 |
| GALA | Galactosidase – Alpha* | 6 weeks | 360 |
| GANG | Ganglioside GM1, GD1B, GQ1B Abs | 5 days | 279 |
| GASP | Gastric Parietal Autoantibodies | 2 days | 62 |
| GBSX | Group B Strep – Vaginal and Rectal (Self-collect) | 3-5 days | 63 |
| GBSX | Group B Strep – Vaginal and Rectal (STM) | 3-5 days | 63 |
| GENT | Gentamicin Assay | 1 day | 132 |
| GGT | Gamma GT | 1 day | 32 |
| GH | Growth Hormone (Fasting) | 1 day | 71 |
| GHB | HbA1c (Venous) | 1 day | 63 |
| GLOB | Globulin (Calculated) | 1 day | 38 |
| GLUG | Glucagon | 10 days | 257 |
| GLUT | Gluten Sensitivity Profile | 10 days | 424 |
| GRIM | Granulocyte Immunology | 2 weeks | 515 |
| GRP | Azoospermia – karyotype + Y deletions + cystic fibrosis screen (+ polyT(5T) when clinically relevant) | 10-15 days | 1076 |
| GRP | Congenital Absence of Vas Deferens – karyotype + Y deletions + cystic fibrosis screen (+ polyT(5T) when clinically relevant) | 10-15 days | 1076 |
| GRP | Genetic Reproductive Profile (Male) | 10-15 days | 1076 |
| GRP | Male Genetic Reproductive Profile | 10-15 days | 1076 |
| GSA | Coeliac/Gluten Sensitivity Profile | 2 days | 195 |
| GSA | Gluten Sensitivity Evaluation | 2 days | 195 |
| GSA2 | Coeliac/Gluten Genetic Profile 2 | 10 days | 410 |
| GSA2 | Gluten/Coeliac Genetic Profile 2 | 10 days | 410 |
| GTT | Glucose Tolerance Test/OGTT | 1 day | 183 |
| GTT + GHDF | Glucose Tolerance with Growth Hormone | 1 day | 306 |
| GTTE | Glucose Tolerance Test (Extended) | 1 day | 301 |
| GTTI | Glucose Tolerance with Insulin | 1 day | 457 |
| GTTS | Glucose Tolerance Test (Short) | 1 day | 117 |
| GTTX | Glucose Tolerance Test (Extended Plus) | 1 day | 338 |
| GUTH | Newborn Screening Panel | 2 weeks | 218 |
| HABC | HLA Tissue Typing A+B+C (Class I) | 10 days | 713 |
| HAIM | Hepatitis A Immunity (IgG/IgM) | 1 day | 62 |
| HANT | Histoplasma Antigen | 3 days | 202 |
| HANV | Hantavirus Serology | 10 days | 158 |
| HAPT | Haptoglobin | 5 days | 87 |
| HAVM | Hepatitis A (IgM) | 1 day | 59 |
| HAVR | Hepatitis A RNA by PCR | 3 weeks | 281 |
| HB | Haemoglobin | 1 day | 38 |
| HBAG | H. pylori Antigen – Stool (RF) | 3 days | 93 |
| HBAG | H. pylori Antigen – Stool (Self-collect) | 3 days | 93 |
| HBE | Hepatitis E IgG/IgM | 5 days | 165 |
| HBEL | Haemoglobin Electrophoresis | 4 days | 121 |
| HBEL | Thalassaemia Screen | 4 days | 121 |
| HBPA | H. pylori Antibodies (IgG) | 2 days | 88 |
| HCGF/PAPA | Down Syndrome Risk Bloods only (Risk to be calculated by clinician) | 1 day | 104 |
| HCGQ | HCG (Oncology) | 1 day | 68 |
| HCO3 | Bicarbonate | 1 day | 29 |
| HCRP | C Reactive Protein (High Sensitivity) (Venous) | 1 day | 62 |
| HCYS | Homocysteine (Urine) | 2 weeks | 156 |
| HDAG | Hepatitis Delta Antigen | 5 days | 179 |
| HDL | HDL Cholesterol | 1 day | 51 |
| HE4 | HE4 + ROMA (Earlier Detection of Ovarian Tumour) | 1 day | 159 |
| HEPD | Hepatitis Delta Antibody | 5 days | 139 |
| HINF | Haemophilus B Influenzae Antibodies | 5 days | 132 |
| HIRP | Hirsutism Profile | 1 day | 212 |
| HISA | Histone Antibodies | 5 days | 128 |
| HISP | Histoplasmosis | 10 days | 173 |
| HITU | Histamine (Urine) | 5 days | 158 |
| HL57 | HLA B*57:01 | 10 days | 401 |
| HL57 | HLA Tissue Typing B*57:01 high resolution | 10 days | 401 |
| HLA | HLA Tissue Typing A | 10 days | 276 |
| HLAB | HLA B27 | 3 days | 256 |
| HLAB | HLA Tissue Typing B*27 only | 3 days | 256 |
| HLAF | HLA Tissue Typing A/B/DRB1/3/4/5 | 10 days | 713 |
| HLB | HLA Tissue Typing B | 10 days | 276 |
| HLBA | HLA Tissue Typing A+B | 10 days | 436 |
| HLC | HLA Tissue Typing C | 10 days | 276 |
| HLDQ | HLA Tissue Typing DRB1/3/4/5/DQB1 (Class II) | 10 days | 436 |
| HLF | HLA Tissue Typing A/B/DRB1/3/4/5/DQB1 | 10 days | 786 |
| HLFC | HLA Tissue Typing A/B/C/DRB1/3/4/5/DQB1 (Class I & II) | 10 days | 932 |
| HMD | Haemochromatosis – HFE common variants C282Y + H63D | 3 days | 269 |
| HMD | HFE gene (Haemochromatosis) – common variants C282Y + H63D | 3 days | 269 |
| HOMO | Homocysteine (Quantitative) | 1 day | 111 |
| HPCU | H. pylori Culture | 1 month | 252 |
| HRT | HRT Profile 1 | 1 day | 129 |
| HRT2 | HRT Profile 2 | 1 day | 197 |
| HSID | Haemosiderin (Urine) | 2 weeks | 128 |
| HSNK | NK Cytotoxicity Assay | Send Mon-Thurs only | 760 |
| HTLP | HTLV by PCR | 21 days | 408 |
| HTLV | HTLV 1 & 2 Abs. (Human T Lymphotropic Virus Type I-II) | 1 day | 76 |
| HVA | Homovanillic Acid (HVA) | 5 days | 121 |
| HVS | HVS | 2-4 days | 93 |
| IBIL | Bilirubin (Indirect) | 1 day | 35 |
| ICAB | Islet Cell Antibodies | 3 days | 82 |
| ICPA | Ionised Calcium | 5 days | 62 |
| IFAB | Intrinsic Factor Antibodies | 2 days | 124 |
| IGA | Immunoglobulin A | 1 day | 50 |
| IGD | Immunoglobulin D | 5 days | 86 |
| IGE | IgE (Total) | 1 day | 68 |
| IGE | Immunoglobulin E – Total | 1 day | 68 |
| IGE | Total IgE | 1 day | 68 |
| IGE | Total Immunoglobulin E | 1 day | 68 |
| IGF2 | Insulin-Like Growth Factor 2 | 1 month | 369 |
| IGG | Immunoglobulin G | 1 day | 50 |
| IGHA | B cell Clonality Assay (IgH and IgK) | 2 weeks | 510 |
| IGM | Immunoglobulin M | 1 day | 50 |
| IGMU | IgVH variant analysis for CLL | 4 weeks | 510 |
| IGSC | IgG Subclasses | 5 days | 279 |
| IHCS | Immunofluorescence in Skin Biopsies | 2 weeks | 613 |
| IL28 | Interleukin 28b Genotype | 2 weeks | 502 |
| IMCP | C1q Binding Immune Complex | 5 days | 121 |
| IMCP | Immune-Complexes | 5 days | 121 |
| IMIP | Imipramine | 4 days | 117 |
| IMM | Immunoglobulins (IgG, IgM, IgA) | 1 day | 100 |
| IMPO | Erectile Dysfunction Profile | 3 days | 281 |
| IMPO | Impotence Profile | 3 days | 281 |
| INAB | Insulin Antibodies | 5 days | 116 |
| INIA | Inhibin A | 1 month | 194 |
| INSU | Insulin | 1 day | 68 |
| INTE | HIV-1 Genotypic Resistance (Integrase) | 21 days | 779 |
| IODI | Iodine – Serum | 1 week | 133 |
| IOP | Iron Overload Profile | 3 days | 346 |
| ISAC | ISAC Panel (Venous) | 3 days | 380 |
| ISP | Iron Status Profile (Venous) | 1 day | 111 |
| IUCD | IUCD for Culture | 11-12 days | 93 |
| K | Potassium | 1 day | 32 |
| KARY | Chromosome Analysis (Blood) | 2-3 weeks | 539 |
| KCCT | APTT/KCCT | 1 day | 50 |
| KETA | Ketamine Screen | 7-10 days | 177 |
| LACG | Lactose Intolerance Gene | 2 weeks | 189 |
| LACT | Lactate (Plasma) | 1 day | 94 |
| LAMO | Lamotrigine | 5 days | 139 |
| LDH | Lactate Dehydrogenase (LDH) | 1 day | 41 |
| LDL7 | LDL7 Subfractions | 10 days | 297 |
| LE | Lysosomal Enzyme Screen | 2 months | 896 |
| LEAD | Lead (Blood) | 5 days | 71 |
| LEGA | Legionella Urine Antigen | 1 day | 119 |
| LEGO | Legionella Antibodies | 3 days | 96 |
| LEIS | Leishmania Antibodies | 5 days | 76 |
| LEL | Lipoprotein Electrophoresis | 5 days | 98 |
| LEP | Leptospirosis (Weil’s Disease) Abs (IgM) | 5 days | 142 |
| LEPT | Leptin | 5 days | 188 |
| LEVE | Levetiracetam (Keppra) | 3 days | 147 |
| LFT | Liver Function Tests (Venous) | 1 day | 63 |
| LH | Luteinising Hormone (LH) (Venous) | 1 day | 63 |
| LIPA | Lipase (Venous) | 1 day | 66 |
| LIPP | Lipid Profile (Venous) | 1 day | 63 |
| LITH | Lithium | 1 day | 59 |
| LIVI | Liver Immunoblot | 3 days | 212 |
| LKM | Liver Kidney Microsomal Antibodies | 2 days | 62 |
| LMPX | Leukaemia Fusion Gene Screening Assay (Q30) | 24 hours | 692 |
| LORA | Lorazepam | 10 days | 82 |
| LPOA | Lipoprotein (a) (Venous) | 1 day | 70 |
| LPR | Lactate Pyruvate Ratio | 4-6 weeks | 166 |
| LSA | Anti-SLA (Soluble Liver Antigen) Abs | 5 days | 142 |
| LSD | LSD | 5 days | 137 |
| LSDS | Lysosomal Storage Disorders NGS Panel – full gene sequencing . Requires patient informed consent | 4-6 weeks | 1078 |
| LTT | Lactose Tolerance Test | 1 day | 175 |
| LUPA | Hughes Syndrome | 2 days | 133 |
| LUPA | Lupus Anticoagulant and Anticardiolipin Abs | 2 days | 133 |
| LUPC | Lupus Anticoagulant only | 2 days | 87 |
| LYPT | Leukaemia Immunophenotyping | 5 days | 666 |
| LYSO | Lysozyme | 5 days | 103 |
| LYSS | CD3/CD4/CD8 | 1 day | 295 |
| LYSS | Lymphocyte Subsets (CD3/CD4/CD8) | 1 day | 295 |
| M2ST | Pyruvate Kinase (M2-PK) | 5 days | 114 |
| MAG | Myelin Associated Glycoprotein Antibodies | 5 days | 373 |
| MALA | Malarial Antibodies (Pl. falciparum) | 5 days | 88 |
| MALP | Malarial Parasites | STAT | 71 |
| MALS | Malarial Antibodies (species specific) | 10 days | 114 |
| MANG | Manganese (Serum) | 5 days | 91 |
| MBOC | MBOCA in Urine | 10 days | 137 |
| MBPA | Myelin Basic Protein Antibodies | 2 weeks | 121 |
| MCV | Mean Cell Volume (MCV) | 1 day | 41 |
| MDR | Carbapenemase producing organism screen | 4-5 days ‡ | 133 |
| MEAM | Measles Antibodies (IgM) | 2 days | 87 |
| MEAP | Measles PCR | 48 hours | 169 |
| MEAS | Measles Antibodies (IgG) Immunity | 1 day | 87 |
| MENI | Meningococcal Serology (only serogroup C) | 6 weeks | 117 |
| MENO | Menopause Profile (Venous) | 1 day | 172 |
| MERC | Mercury (Blood) | 5 days | 71 |
| MERS | MERS Coronavirus Test | 1 day | 212 |
| METQ | Methaqualone | 5 days | 48 |
| METR | Metronidazole Level | 10 days | 117 |
| METS | Metabolic Syndrome Profile | 9 days | 344 |
| METX | Methotrexate | 2 days | 167 |
| MG | Magnesium (Serum) | 1 day | 50 |
| MGE | Myasthenia Gravis Evaluation | 5 days | 198 |
| MICF | Microfilaria Blood Film | STAT | 43 |
| MINE | Mineral Screen | 5 days | 228 |
| MIPR | Male Hormone Profile | 1 day | 211 |
| MMA | Methylmalonic Acid – Urine | 2 weeks | 167 |
| MMAS | Methylmalonic Acid – Serum | 5 days | 268 |
| MMR | Measles, Mumps, Rubella (MMR) | 1 day | 186 |
| MOCP | Stool for OVA Cysts & Parasites by Microscopy | 2 days | 48 |
| MOLY | Molybdenum (Serum) | 5 days | 90 |
| MP48 | Malarial Parasites (visa, non-urgent) | 2 days | 71 |
| MPCP | Pneumocystis jiroveci (PJP) PCR | 2-3 days | 120 |
| MPCR | Mycoplasma species – DNA | 5 days | 260 |
| MPNS | Myeloproliferative Neoplasm NGS Screening Panel . Requires patient informed consent | 1 week | 634 |
| MPO | Myeloperoxidase Antibodies | 2 days | 70 |
| MRS2 | MRSA (Rapid PCR) one swab per site x 2 | 1 day | 177 |
| MRS2 | MRSA PCR (Self-collect) – Nose/Groin | 1 day | 177 |
| MRSA | MRSA (Rapid PCR) one swab per site | 1 day | 89 |
| MRSW | MRSA Culture one swab per site | 2 days | 63 |
| MRW2 | MRSA Culture one swab per site x 2 | 2 days | 127 |
| MRW2 | MRSA Culture (Self-collect) – Nose/Groin | 2 days | 127 |
| MSTT | Testosterone (Total), LC MS Mass Spec | 5-7 days | 129 |
| MSTT | Total Testosterone, LC MS Mass Spec | 5-7 days | 129 |
| MTHF | MTHFR – common C677T + A1298C variants | 5 days | 276 |
| MTM2 | Mitochondrial Antibodies M2 | 2 days | 272 |
| MUMM | Mumps Antibodies (IgM) | 1 day | 87 |
| MUMP | Mumps Antibodies (IgG) | 1 day | 87 |
| MUSK | Anti-MUSK Antibodies | 2 weeks | 392 |
| MVPS | Myeloid Gene Panel . Requires patient informed consent | 2 weeks | 760 |
| MYCO | Mycoplasma pneumoniae IgM and IgG | 2 days | 77 |
| MYCP | Mycophenolic Acid (Cellcept) | 5 days | 167 |
| MYEL | Myeloma Screen | 5 days | 183 |
| MYO | Myocardial Antibodies | 1 week | 94 |
| MYOS | Myositis Panel | 3 days | 137 |
| NA | Sodium | 1 day | 32 |
| NASS | Swab (Nasal) | 2-4 days | 93 |
| NCIT | Suppression with steroid, IVIg and intralipin, NK (CD69) cell assay, TH1/TH2 cytokines | Send Mon-Thurs only | 1216 |
| NCOV | COVID-19 (SARS-CoV-2) (PCR) | 1 day | 215 |
| NCOV | COVID-19 (SARS-CoV-2) RNA by PCR (Self-collect) | 1 day | 215 |
| NEUR | Neuronal Antibody (Hu, Ri, Yo, Cv2, Ma2) | 10 days | 357 |
| NICK | Nickel (Serum) | 5 days | 90 |
| NICU | Nickel (Urine) | 4 weeks | 96 |
| NIPT | Non-Invasive Prenatal Testing (NIPT) – common aneuploidy screening from maternal blood | 2-4 days | 339 |
| NKCY | NK Cytotoxicity with suppression, steroid, IVIg & Intralipin | Send Mon-Thurs only | 970 |
| NKP2 | Natural Killer Profile 2 | 2 days | 324 |
| NMDA | NMDA Receptor Antibodies | 3 weeks | 262 |
| NSE | Neurone Specific Enolase | 5 days | 211 |
| NSI | Needle Stick Injury Profile | 1 day | 220 |
| NVIR | Neurological Viral Screen | 2 days | 218 |
| OCP | Cryptosporidium | 2 days | 93 |
| OEST | Oestradiol-17-Beta (Venous) | 1 day | 63 |
| OLAN | Olanzapine | 5 days | 147 |
| OMG3 | Omega 3/Omega 6 (Venous) | 5 days | 149 |
| OPS | Osteoporosis Screen | 4 days | 205 |
| ORSW | Swab (Oral) | 2-4 days | 92 |
| OSMO | Osmolality (Serum) | 1 day | 61 |
| OVAB | Ovarian Autoantibodies | 3 days | 88 |
| P1NP | Procollagen 1 Peptide N-Terminal (NTX) | 5 days | 343 |
| PAIP | PAI-1 4G/5G Polymorphism | 10 days | 237 |
| PALB | Prealbumin | 3 days | 102 |
| PAPT | Cervical Cytology | 6 days (combined report) | 56 |
| PAPT + HP20 | Cervical Cytology + HP20 | 6 days (combined report) | 232 |
| PARA | Paracetamol | 1 day | 138 |
| PARG | Parvovirus Antibodies (IgG) | 2 days | 97 |
| PARP | Parvovirus IgG/IgM Abs | 2 days | 110 |
| PARV | Parvovirus Antibodies (IgM) | 2 days | 108 |
| PASS | Pneumococcal Antibodies – Serotype Specific | 5 weeks | 311 |
| PAUL | Paul Bunnell (Monospot) | 1 day | 31 |
| PCOP | Polycystic Ovary Syndrome Profile | 5 days | 661 |
| PCOS | Polycystic Ovary Syndrome SHORT | 1 day | 210 |
| PCRB | Babesia PCR | 7 days | 125 |
| PCRP | Human Parvovirus B19 – DNA | 2 weeks | 244 |
| PENS | Swab (Penile) | 2-4 days | 92 |
| PENT | Stool for OCP and Culture by PCR | 2-3 days | 44 |
| PERP | Pertussis (Whooping Cough) by PCR | 2-3 days | 199 |
| PERP | Whooping Cough (Pertussis) by PCR | 2-3 days | 199 |
| PERS | Pertussis (Whooping Cough) Antibodies | 5 days | 107 |
| PERS | Whooping Cough (Pertussis) Antibodies | 5 days | 107 |
| PETH | PEth (Phosphatidylethanol) (Venous) | 5-7 days | 129 |
| PFAT | Platelet Function Test Screen – PFA-100/200 | 1 day | 190 |
| PHB | Phenobarbitone | 1 day | 75 |
| PHEN | Epanutin (Phenytoin) | 1 day | 75 |
| PHEN | Phenytoin (Epanutin) | 1 day | 75 |
| PHFP | Leukaemia/Lymphoma RNA Sequencing (Fusion Gene and SNV/Indel) Panel . Requires patient informed consent | 2 weeks | 1078 |
| PHOS | Phosphate | 1 day | 32 |
| PHTS | Anti-Phosphatidylserine Antibodies | 5 days | 173 |
| PITF | Pituitary Function Profile | 1 day | 234 |
| PITU | Pituitary Antibodies | 1 month | 119 |
| PLA2 | Lp-PLA2 (PLAC) Test | 2 days | 142 |
| PLA2 | PLAC Test (Lp-PLA2) (Venous) | 2 days | 142 |
| PLAG | Platelet Aggregation Studies | 3 days | 385 |
| PNAG | Pneumococcal Antigen | 1 day | 120 |
| PNEU | Pneumococcal Antibody Screen | 5 days | 129 |
| POMP | Glycogen storage disease type 2 (Pompe) variant analysis | 4 weeks | 1193 |
| PORP | Porphyrin (Blood) | 15 days | 263 |
| PORS | Porphyrin Full Screen (Total: Urine, Stool, Blood) | 3 weeks | 599 |
| PP | Pancreatic Peptide | 4 weeks | 266 |
| PR2 | Prostate Profile (Total & Free PSA) | 1 day | 111 |
| PR3 | Proteinase 3 Ab | 2 days | 68 |
| PRCO | Procollagen 3 Peptide | 5 days | 192 |
| PREG | Pregnancy Test (Urine) | 1 day | 46 |
| PREN | Pregnenolone | 15 days | 142 |
| PRGM | Paragomius Serology | 2 weeks | 163 |
| PRIM | Mysoline (Primidone) | 3 days | 88 |
| PRIM | Primidone (Mysoline) | 3 days | 88 |
| PRLD | Macroprolactin | 4 days | 298 |
| PRLD | Prolactin (Macro) | 4 days | 298 |
| PRO | Propanalol | 7 days | 132 |
| PROG | Progesterone (Venous) | 1 day | 63 |
| PROL | Prolactin (Venous) | 1 day | 63 |
| PROP | Miscarriage/Thrombotic Risk Profile | 5 days | 873 |
| PROP | Thrombotic Risk Profile | 5 days | 873 |
| PROT | Protein Total (Blood) | 1 day | 32 |
| PROZ | Fluoxetine (Prozac) | 5 days | 147 |
| PRTE | Protein Electrophoresis incl. immunoglobulin | 5 days | 129 |
| PSPA | Prostate Specific Antigen (Total) (Venous)* | 1 day | 82 |
| PTHA | Parathyroid Antibodies | 3 weeks | 113 |
| PTHI | Parathyroid Hormone (Whole) | 1 day | 144 |
| PTIM | INR | 1 day | 35 |
| PTIM | Prothrombin Time | 1 day | 35 |
| PTS | Post-Travel Screen 1 (Up to 6 weeks post travel) | 10 days | 309 |
| PTS2 | Post-Travel Screen 2 (6 weeks after travel) | 10 days | 581 |
| PURK | Purkinje Cell Antibody (Hu and Yo) | 10 days | 76 |
| PWAM | Angelman Syndrome (Primary Screen) – methylation test | 10 days | 570 |
| PWAM | Prader-Willi Syndrome (Primary Screen) – methylation test | 10 days | 570 |
| Q2Q8 | Coeliac Disease – HLA DQ2/DQ8 Genotype | 10 days | 240 |
| Q2Q8 | HLA Tissue Typing Coeliac Disease – DQ2/DQ8 | 10 days | 240 |
| QCAL | Calprotectin/QFIT Profile (Combined) (QFIT) | 5 days | 177 |
| QCAL | Calprotectin/QFIT Profile (Combined) (Self-collect) | 5 days | 177 |
| QCAL | QFIT/Calprotectin Profile (Combined) (QFIT) | 5 days | 177 |
| QCAL | QFIT/Calprotectin Profile (Combined) (Self-collect) | 5 days | 177 |
| QCYS | Cystine – Quantitative (Beta-CTX) | 5 days | 150 |
| QFEV | Q Fever (C Burnetti) Antibodies | 10 days | 83 |
| QFIT | Quantitative Faecal Immunochemical Test (QFIT) | 1 day | 68 |
| QFIT | Quantitative Faecal Immunochemical Test (QFIT) (Self-collect) | 1 day | 68 |
| QHCG | HCG (Quantitative) (Venous) | 1 day | 70 |
| QHCG | Pregnancy (Serum) [Quantitative] | 1 day | 70 |
| QPCR | Hepatitis C Quantification (Viral Load) | 5 days | 286 |
| R90U | Bleeding and Platelet Gene Panel . Requires patient informed consent | 12 weeks | 1309 |
| R90U | Inherited bleeding and platelet disorders (R90) | 12 weeks | 1309 |
| R97U | Thrombophilia with a likely monogenic cause (R97) | 12 weeks | 1309 |
| RABI | Rabies Antibody | 20 days | 185 |
| RAPS | Rapid Strep PCR (incl. m/c/s) | 1-3 days** | 96 |
| RBCF | Folate (Red Cell) | 2 days | 60 |
| RBCF | Vitamin B9 (Folic acid) – Red cell | 2 days | 60 |
| RBCZ | Zinc (Whole Blood) | 5 days | 62 |
| RBG | Glucose | 1 day | 33 |
| RBGM | Glucose Challenge Test/Mini-GTT | 1 day | 38 |
| RBJP | Bence-Jones Protein | 5 days | 117 |
| RBP | Retinol Binding Protein | 3 days | 76 |
| RCMG | Magnesium (Whole blood) | 4 days | 111 |
| RECG | Swab (Rectal) | 2-4 days | 93 |
| RETC | Reticulocyte Count | 1 day | 38 |
| RF | Rheumatoid Factor (Latex Test) | 3 days | 41 |
| RH | Rheumatology Profile 1 (Screen) | 2 days | 165 |
| RH2 | Rheumatology Profile 2 (Connective tissue) | 3 days | 487 |
| RH3 | Rheumatology Profile 3 (Rheumatoid/Basic) | 2 days | 238 |
| RH4 | Rheumatology Profile 4 (Systemic Lupus) | 2 days | 366 |
| RH5 | Rheumatology Profile 5 (Mono Arthritis) | 3 days | 350 |
| RH6 | Rheumatology Profile 6 (Rheumatoid Plus) | 3 days | 121 |
| RH7 | Rheumatology Profile 7 (Sjogren’s Syndrome) | 15 days | 121 |
| RH7 | Sjogren’s Syndrome | 15 days | 121 |
| RIBA | Hepatitis C Abs Confirmation (RIBA) | 5 days | 216 |
| RICK | Rickettsial Species Antibody Profile | 7 days | 133 |
| RISP | Risperidone | 7 days | 227 |
| RMIN | Mineral Screen (Whole blood) | 5 days | 248 |
| RMP | Recurrent Miscarriage Profile (female) | 10-15 days | 1277 |
| RNAP | RNA Polymerase Antibodies | 3 days | 81 |
| ROSM | Osmolality (Urine) | 1 day | 59 |
| ROTA | Rotavirus in Stool by PCR | 1 day | 119 |
| RPOR | Porphyrin (Urine) | 3 weeks | 194 |
| RSPR | Renal Calculi Screen (Metabolic) | 5 days | 212 |
| RSTA | Gall Stone Analysis | 10 days | 219 |
| RSTA | Renal Stone Analysis | 10 days | 219 |
| RT3 | Reverse T3 | 15 days | 156 |
| RT3 | T3 (Reverse) | 15 days | 156 |
| RU5H | 5 HIAA | 5 days | 119 |
| RUAL | Aminolevulinic Acid (Urine) | 5 days | 81 |
| RUAV | Rubella Avidity | 1 week | 173 |
| RUBE | Rubella Antibody (IgG) | 1 day | 64 |
| RUBM | Rubella Antibody (IgM) | 1 day | 91 |
| RUBP | Rubella PCR | 5 days | 207 |
| S100 | S100 Malignant Melanoma | 4 days | 158 |
| SAA | Amyloidosis (Amyloid A Protein) | 5 days | 124 |
| SAB | Salivary Duct Antibodies | 15 days | 71 |
| SALI | Salicylates | 1 day | 67 |
| SCA | Steroid Cell Antibody | 2 days | 111 |
| SCC | Squamous Cell Carcinoma | 4 days | 243 |
| SCLI | Scleroderma Immunoblot | 3 days | 212 |
| SCOV | COVID-19 (SPIKE) Antibodies (Venous) | 1 day | 63 |
| SDPD | Crosslaps (Serum DPD) | 4 days | 123 |
| SDPD | Deoxypyridinoline (DPD) – Serum | 4 days | 123 |
| SELE | Selenium (Serum) (Venous) | 4 days | 88 |
| SELL | Sellotape Test | 1 day | 96 |
| SGAL | Galactomanan (Aspergillus Antigen) | 2 weeks | 190 |
| SHBG | Sex Hormone Binding Globulin (Venous) | 1 day | 75 |
| SILV | Silver (Blood) | 5 days | 124 |
| SIRO | Sirolimus | 3 days | 154 |
| SKAB | Pemphigus/Pemphigoid Autoantibodies | 2 days | 75 |
| SKAB | Skin (Pemphigus/Pemphigoid) Autoantibodies | 2 days | 75 |
| SKIS | Swab (Skin) | 2-4 days | 93 |
| SLC | Serum Free Light Chains | 5 days | 376 |
| SMA | Spinal Muscular Atrophy – SMN1 deletions/duplications | 10 days | 567 |
| SMYO | Myoglobin (Serum) | 1 day | 87 |
| SODI | Superoxide Dismutase | 5 days | 123 |
| SPOR | Sports/Performance Profile | 5 days | 635 |
| SPU1 | Sputum for Routine Culture | 2-4 days | 102 |
| SPU2 | Sputum for TB Culture (AFB) | up to 8 weeks | 102 |
| SPU2 | TB Culture | up to 8 weeks | 102 |
| SRY | SRY (Sex-determining Region Y) | 2 days | 234 |
| STGA | Strongyloides Antibodies | 10 days | 136 |
| STK3 | Stockholm3 | 2 weeks | 356 |
| STKR | Stockholm3 Reflex | 2 weeks | 356 |
| STRA | Striated/Skeletal Muscle Antibody | 3 days | 62 |
| STRM | Streptomycin Levels | 5 days | 197 |
| STRS | Stool Reducing Substances | 2-3 weeks | 63 |
| STRY | Tryptase | 2 days | 181 |
| STSK | Skin Antibodies by Immunofluorescence | 1 month | 282 |
| SULP | Sulpiride | 4 days | 139 |
| SYNA | Synacthen Stimulation Test | 1 day | 306 |
| T3 | T3 | 1 day | 63 |
| T4 | Thyroxine (T4) | 1 day | 58 |
| TAA | Tissue Transglutaminase IgA (Coeliac) (Venous)** | 2 days | 76 |
| TAAG | Tissue Transglutaminase IgG | 5 days | 90 |
| TB12 | Vitamin B12 (Total) | 1 day | 66 |
| TBCU | TB (Pleural Fluid) | up to 8 weeks | 102 |
| TBPC | TB PCR (PCR detection of Mycobacterium tuberculosis complex and mutations for Rifampicin resistance) | 1 day | 228 |
| TBQ4 | TB Quantiferon®-TB Gold* | 3 days | 136 |
| TBSL | TB Slopes – Confirmation and Sensitivity | up to 8 weeks | 241 |
| TBUR | TB Culture (Urine) | up to 8 weeks | 217 |
| TCRA | T cell Clonality Assay (TCR beta and TCR gamma) | 2 weeks | 510 |
| TDM | HIV Therapeutic Drug Monitoring | 21 days | 319 |
| TDYE | Toxoplasma Antibody Full Evaluation (IgM, Dye Test, IgG Avidity) | 10 days | 172 |
| TEIC | Teicoplanin Assay | 5 days | 139 |
| TEMA | Temazepam | 4 days | 154 |
| TEST | Testosterone (Venous) | 1 day | 63 |
| TETA | Tetanus Antibody | 5 days | 128 |
| TF | Thyroid Profile 1 (FT4/TSH) (Venous) | 1 day | 88 |
| TF2 | Thyroid Profile 2 (Venous) | 2 days | 209 |
| TF3 | Thyroid Profile 3 (FT3/FT4/TSH) (Venous) | 1 day | 125 |
| TFAM | Toxoplasma Antibodies (IgG, IgM) | 1 day | 94 |
| TFAT | Toxocara Antibodies (IgG) | 5 days | 94 |
| TFFA | Faecal Fat (1 day collection) | 5 days | 185 |
| TFIF | Bancroftia/Oncerciasis/Filarial Antibodies | 2 weeks | 196 |
| TGA | Thyroglobulin Assay | 1 day | 111 |
| TGAB | Thyroglobulin Abs | 1 day | 64 |
| TGN | 6-Thioguanine Nucleotides | 2 weeks | 208 |
| THAB | Thyroid Abs (Thyroglobulin + Thyroid Peroxidase Abs) (Venous) | 1 day | 105 |
| THAL | Thallium (Blood) | 1 week | 90 |
| THEO | Theophylline | 1 day | 66 |
| THRO | Thrombin Time | 1 day | 40 |
| THRS | Swab (Throat) | 2-4 days | 93 |
| TIE | Immune Function Evaluation (Total) | 7 days | 424 |
| TIE | Total Immune Function Evaluation | 7 days | 424 |
| TISS | Tissue for culture | up to 14 days | 102 |
| TOBR | Tobramycin Assay (Provide Clinical Details) | 3 days | 248 |
| TOL | Toluene (Blood) | 10 days | 171 |
| TOPI | Topiramate (Topamax) | 4 days | 132 |
| TORC | Torch Screen | 2 days | 228 |
| TPA | Tissue Polypeptide Antigen | 1 week | 208 |
| TPEX | Thyroid Peroxidase Antibodies/Anti TPO | 1 day | 64 |
| TPMT | Thiopurine Methyl Transferase | 5 days | 173 |
| TRAC | Mineral Screen and Industrial Heavy Metal Screen (Trace Metals) | 7-10 days | 360 |
| TRAC | Trace Metal (Blood) Profile | 7-10 days | 360 |
| TRAN | Transferrin | 1 day | 98 |
| TREL | Transferrin Electrophoresis | 2 weeks | 317 |
| TRI | Triglycerides | 1 day | 38 |
| TRIC | Trichinella Serology | 5 days | 119 |
| TRIM | Trimipramine | 5 days | 110 |
| TROC | Troponin I (High sensitive) | 1 day | 114 |
| TROP | Tropical Screen (from 6 weeks post-travel) | 10 days | 263 |
| TROT | Troponin T (High sensitive) | 1 day | 124 |
| TRPM | HIV-1 Tropism | 28 days | 1194 |
| TRYP | Sleeping Sickness Serology (African Trypanosomiasis) | 10 days | 239 |
| TSH | TSH (Venous) | 1 day | 63 |
| TSI | TSH-Receptor Antibodies | 4 days | 190 |
| TTP | Testicular Tumour Profile (LDH, AFP, HCQG) | 1 day | 154 |
| TTVT | Taipan Snake Venom Time | 2-3 weeks | 289 |
| TULA | Tularaemia Antibodies | 5 days | 123 |
| TXAG | Toxoplasma by PCR | 5 days | 197 |
| U/E | Urea and Electrolytes | 1 day | 64 |
| UA | Urate (Uric acid) | 1 day | 38 |
| UA | Uric Acid (Serum) | 1 day | 38 |
| UALC | Alcohol (Urine) | 1 day | 97 |
| UALD | Aldosterone (Urine) | 5 days | 160 |
| UAMY | Amylase (Urine) | 1 day | 59 |
| UB2M | Beta 2 Microglobulin (Urine) | 3 days | 125 |
| UBC | Urinary Bladder Cancer Antigen | 5 days | 106 |
| UCA | Calcium (24 hour Urine) | 1 day | 38 |
| UCAT | Catecholamines (Urine) | 5 days | 181 |
| UCEM | Urine Chemistry, Microscopy and Culture (Self-collect) | 1-2 days | 78 |
| UCEM | Urine for Microscopy and Culture | 1-2 days | 78 |
| UCOC | Cocaine (Urine) Screen | 1 day | 36 |
| UCOR | Cortisol (Urine) | 5 days | 90 |
| UCPR | Protein/Creatinine Ratio (Urine) | 1 day | 88 |
| UCR | Creatinine (Urine) | 1 day | 48 |
| UCXD | Urine for Extended Culture | up to 7 days | 169 |
| UDHE | DHEA – Urine (Dehydroepiandrosterone) | 3 weeks | 119 |
| UELE | Electrolytes (Urine) | 1 day | 50 |
| UFL | Fluoride (Urine) | 5 days | 137 |
| UHYD | Hydroxyprolene | 2 weeks | 114 |
| UIOD | Iodide – Urine | 1 week | 159 |
| UMA | Urine Microalbumin/Creatinine Ratio | 1 day | 88 |
| UMEL | Melatonin (Urine) | 2 weeks | 166 |
| UMEX | Metanephrines (Urine) | 5 days | 172 |
| UMIC | Urine (Microscopy Only) | 1 day | 60 |
| UMIC | Urine Chemistry and Microscopy (Self-collect) | 1-2 days | 60 |
| UMYO | Myoglobin (Urine) | 5-10 days | 123 |
| UOLI | Oligosaccharides | 6 weeks | 274 |
| UOPI | Opiate Screen (Urine) | 2 days | 68 |
| UOXA | Oxalate (Urine) | 5 days | 103 |
| UPH | Phosphate (24 hour Urine) | 1 day | 50 |
| UPRT | Protein (Urine) | 1 day | 48 |
| URCD | Cadmium (Urine) | 5 days | 96 |
| URCR | Chromium (Urine) | 4 weeks | 84 |
| URCU | Copper (Urine) | 5 days | 71 |
| URCY | Urine Cytology (Urine cytology containers available from TDL Supplies) | 2 days | 174 |
| UREA | Urea (Venous) | 1 day | 38 |
| URES | Swab (Urethral) | 2-4 days | 93 |
| URHG | Mercury (Urine) | 5 days | 96 |
| URMG | Magnesium (Urine) | 1 day | 55 |
| URPB | Lead (Urine) | 5 days | 71 |
| URTH | Thallium (Urine) | 1 week | 90 |
| URZN | Zinc (Urine) | 5 days | 63 |
| USCH | Bilharzia (Urine) | 1-2 days | 84 |
| USCH | Schistosoma (Urine) | 1-2 days | 84 |
| USIL | Silver (Urine) | 5 days | 124 |
| USTE | Urine Steroid Screen (Steroid Hormones) | 2 weeks | 967 |
| UTCA | Trichloracetic Acid (Urine) | 5 days | 166 |
| UTOL | Toluene (Urine) | 10 days | 220 |
| UURE | Urea (Urine) | 1 day | 38 |
| UURI | Uric Acid (Urine) | 1 day | 51 |
| UVMA | VMA | 5 days | 87 |
| UXYL | Xylene – Urine | 2 weeks | 124 |
| VAGS | Swab (Vaginal) | 2-4 days | 93 |
| VALP | Valproic Acid (Epilim) | 1 day | 66 |
| VANC | Vancomycin Hydrochloride | 1 day | 110 |
| VB5S | Vitamin B5 (Pantothenic Acid) | 5 days | 159 |
| VBP | Vitamin B Profile | 5 days | 546 |
| VEGF | Vascular Endothelial Growth Factor | 14 days | 261 |
| VIB2 | Vitamin B2 (Riboflavin) | 5 days | 183 |
| VIB3 | Vitamin B3 (Nicotinamide) | 5 days | 183 |
| VIGA | Vigabatrin (Sabril) | 10 days | 132 |
| VIP1 | Chronic Fatigue Syndrome Profile | 5 days | 470 |
| VIRA | Viral Antibody Screen | 2 days | 218 |
| VISC | Viscosity (Plasma) | 3 days | 68 |
| VIT1 | Vitamin B1 (Thiamine) | 5 days | 183 |
| VIT2 | Vitamin Profile 2 | 5 days | 570 |
| VITA | Vitamin A (Retinol) | 5 days | 183 |
| VITB | Vitamin B6 (Pyridoxine) | 5 days | 183 |
| VITD | Vitamin D (25-OH) (Venous) | 1 day | 96 |
| VITE | Vitamin E (Alpha Tocopherol) | 5 days | 192 |
| VITS | Vitamin Profile 1 | 5 days | 380 |
| VKN | Vitamin K (Nutritional) | 5 days | 104 |
| VLDL | VLDL Cholesterol | 1 week | 98 |
| VPCA | Voltage Gated Potassium Channel Antibodies | 3 weeks | 225 |
| VPE | Viral Eye by PCR | 3 days | 147 |
| VPR | Viral Respiratory RNA Screen by PCR | 2 days | 377 |
| VPR | Viral Respiratory RNA Screen by PCR (Self-collect) | 2 days | 377 |
| VPSK | Viral Skin/Mucosa by PCR | 5 days | 132 |
| VULV | Swab (Vulval) | 2-4 days | 93 |
| VWM | Von Willebrands Multimers | 3 months | 728 |
| VZOM | Varicella zoster Antibodies (IgM) | 1 day | 91 |
| VZOS | Varicella zoster Antibodies (IgG) | 1 day | 91 |
| VZPC | Varicella zoster – DNA | 5 days | 328 |
| WNV | West Nile Virus Abs | 2 weeks | 281 |
| WOUS | Swab (Wound) | 2-4 days | 93 |
| XANB | Xanthine – Blood | 2 weeks | 125 |
| XBDG | Beta D Glucan | 3 days | 150 |
| XDNA | DNA Extraction & Storage – 3 years (longer upon request) | 20 days | 212 |
| YDEL | Chromosome Y Deletion – AZFa, AZFb, AZFc + SRY | 5 days | 291 |
| YDEL | Y chromosome microdeletions – AZFa + AZFb + AZFc + SRY | 5 days | 291 |
| YELL | Yellow Fever Antibodies | 10 days | 206 |
| YERS | Yersinia Antibodies | 4 days | 208 |
| ZIKA | Zika RT PCR – Window of detection from 1-7 days from onset of symptoms | Up to 14 days | 262 |
| ZIKU | Zika RT PCR – Window of detection from 1-14 days from onset of symptoms | Up to 14 days | 262 |
| ZINC | Zinc (Serum) | 2 days | 59 |
| ZKAB | Zika Abs IgM and IgG – Antibody detection from 15 days | Up to 14 days | 148 |
| ZZ1 | Alternaria Components | 2 days | 81 |
| ZZ10 | Fish Components | 2 days | 119 |
| ZZ11 | Hazelnut Components | 2 days | 196 |
| ZZ12 | House Dust Mite Components | 2 days | 156 |
| ZZ13 | Latex Components | 2 days | 346 |
| ZZ14 | Olive Components | 2 days | 81 |
| ZZ15 | Peach Components | 2 days | 156 |
| ZZ16 | Peanut Components | 2 days | 233 |
| ZZ17 | Shrimp Components | 2 days | 81 |
| ZZ18 | Soybean Components | 2 days | 156 |
| ZZ19 | Timothy Grass Components | 2 days | 346 |
| ZZ2 | Aspergillus Components | 2 days | 233 |
| ZZ20 | Wall Pellitory Components | 2 days | 81 |
| ZZ21 | Wheat Components | 2 days | 158 |
| ZZ22 | PR-10 Proteins | 2 days | 315 |
| ZZ23 | Lipid Transfer Proteins | 2 days | 274 |
| ZZ24 | Profilins | 2 days | 311 |
| ZZ25 | Polcalcins | 2 days | 119 |
| ZZ26 | Seed Storage Proteins | 2 days | 308 |
| ZZ27 | Glycan Determinants | 2 days | 81 |
| ZZ28 | Lipocalins | 2 days | 119 |
| ZZ29 | Parvalbumins | 2 days | 119 |
| ZZ3 | Birch Components | 2 days | 196 |
| ZZ30 | Serum Albumins | 2 days | 230 |
| ZZ31 | Tropomyosins | 2 days | 119 |
| ZZ32 | Kiwi Components | 2 days | 76 |
| ZZ33 | Venom Components | 2 days | 188 |
| ZZ34 | Walnut Components | 2 days | 119 |
| ZZ35 | Cashew Components | 2 days | 81 |
| ZZ36 | Apple Components | 2 days | 119 |
| ZZ37 | Alpha Gal Components (related to red meat) | 2 days | 81 |
| ZZ38 | Horse Components | 2 days | 46 |
| ZZ39 | Sesame Components | 2 days | 46 |
| ZZ4 | Brazil Components | 2 days | 81 |
| ZZ5 | Cat Components | 2 days | 119 |
| ZZ6 | Celery Components | 2 days | 81 |
| ZZ7 | Cow’s Milk Components | 2 days | 233 |
| ZZ8 | Dog Components | 2 days | 156 |
| ZZ9 | Egg Components | 2 days | 233 |
| APC | QF-PCR rapid common aneuploidy screen | 2 days | 335 |
| CGH | Array-CGH (Comparative Genomic Hybridisation) SNP array | 10 days | 945 |
| CGH | Comparative Genomic Hybridisation (CGH) SNP array | 10 days | 945 |
| DGB | 22q11 & 10p14 deletion (Di George Syndrome) – BOBs only | 5 days | 298 |
| DGB | DiGeorge Syndrome (22q11 & 10p14) - BOBs only | 5 days | 298 |
| DGB, KARY | DiGeorge Syndrome (22q11 & 10p14 deletion) - BOBs (5 days) + karyotype (15 days) | 5-15 days | 837 |
| DGB,KARY | 22q11 & 10p14 deletion (Di George Syndrome) – BOBs (5 days) + karyotype (15 days) | 5-15 days | 837 |
| GENE | Alpha-1-Antitrypsin Genotype - PI*M, PI*S, PI*Z | 3 weeks | 381 |
| GENE | C-KIT D816V variant - Mastocytosis | 4 weeks | 320 |
| GENE | Fragile X Syndrome screen - FMR1 repeat analysis PCR | 5 weeks | 427 |
| GENE | AML/ALL Molecular MRD - NPM1, PML-RARA, CBFB-MYH11, RUNX1-RUNX1T1, ETV6-RUNX1 | 5 days | 482 |
| GENE | Narcolepsy (HLA DQB1*06:02) | 3 weeks | 543 |
| GENE | IDH1/2 Screening Assay | 48 hours | 826 |
| GENE | Familial Hypercholesterolaemia NGS panel | 6 weeks | 761 |
| GENE | 21-Hydroxylase Deficiency (Congenital Adrenal Hyperplasia CYP21A2) |
5 weeks | 862 |
| GENE | Alpha Thalassaemia - multiplex PCR for common large deletions | 3 weeks | 320 |
| GENE | Alpha Thalassaemia - alpha globin gene sequencing + deletions/duplications | 4 weeks | 960 |
| GENE | Adenomatous Polyposis NGS Panel | 4 weeks | 1400 |
| GENE | Achromatopsia NGS Panel | 5 weeks | 2560 |
| GENE | Aicardi-Goutières Syndrome NGS Panel | 5 weeks | 2560 |
| GENE | Alagille Syndrome NGS Panel | 6 weeks | 2560 |
| GENE | Alport Syndrome NGS Panel - full sequencing with deletions and duplications | 5 weeks | 2560 |
| GENE | Alzheimer and Dementia NGS Panel | 6 weeks | 2560 |
| GENE | Systemic Mastocytosis - C-Kit common variants (KIT D816V) | 4 weeks | 320 |
| GENE | Friedreich Ataxia – frataxin gene repeat analysis | 5 weeks | 480 |
| GENE | Gilbert Syndrome - common UGT1A1 repeat variation | 2-3 weeks | 480 |
| GENE | Kennedy Disease (Spinal Bulbar Muscular Atrophy) - AR repeat expansion | 5 weeks | 480 |
| GENE | Spinal Bulbar Muscular Atrophy (Kennedy Disease) - AR repeat analysis | 5 weeks | 480 |
| GENE | HLA Tissue Typing Narcolepsy - DQB1*06:02 | 3 weeks | 559 |
| GENE | Huntington Disease - HD gene repeat analysis PCR | 5 weeks | 560 |
| GENE | Myotonic Dystrophy Type 1 - DMPK repeat PCR | 5 weeks | 560 |
| GENE | Myotonic Dystrophy Type 2 (PROMM) - ZNF9 repeat PCR | 6 weeks | 560 |
| GENE | Leber’s Hereditary Optic Neuropathy – m.3460G>A + m.11778G>A + m.14484T>C common variants | 6 weeks | 672 |
| GENE | Ashkenazi Breast Cancer Screen - common variants | 4 weeks | 680 |
| GENE | Breast Cancer Ashkenazi Screen - common variants | 4 weeks | 680 |
| GENE | Charcot-Marie-Tooth Type 1A - PMP22 duplications | 6 weeks | 680 |
| GENE | Hereditary Neuropathy with Liability to Pressure Palsy - PMP22 deletion analysis | 6 weeks | 680 |
| GENE | Breast Cancer - BRCA1 + BRCA2 genes only | 4 weeks | 720 |
| GENE | Spinocerebellar Ataxia - multiplex SCA1+2+3+6+7+8+10+12+17 common repeat expansions | 5 weeks | 880 |
| GENE | Ashkenazi Jewish Carrier Screen | 4 weeks | 960 |
| GENE | Beckwith-Wiedemann Syndrome - methylation studies on 11p15 imprinting domains KvDMR + H19 | 6 weeks | 960 |
| GENE | Beta Thalassaemia - beta-globin gene sequencing + deletions/duplications | 4 weeks | 960 |
| GENE | Carrier Screen (Ashkenazi Jewish) | 4 weeks | 960 |
| GENE | Carrier Screen (Pan-Ethnic) | 4 weeks | 960 |
| GENE | Silver-Russell Syndrome - methylation studies on 11p15 imprinting domains KvDMR + H19 | 7 weeks | 960 |
| GENE | Tay Sachs Screen | 4 weeks | 960 |
| GENE | Familial Medullary Thyroid Carcinoma - hotspot sequencing RET gene | 6-7 weeks | 1120 |
| GENE | Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency - full G6PD gene sequencing | 3-4 weeks | 1120 |
| GENE | Multiple Endocrine Neoplasia Type 2 - RET gene hotspot sequencing | 6-7 weeks | 1120 |
| GENE | Li-Fraumeni Syndrome (p53-related cancer predisposition) - TP53 sequencing + MLPA | 6 weeks | 1176 |
| GENE | p53-related cancer predisposition (Li-Fraumeni Syndrome) - TP53 sequencing + MLPA | 6 weeks | 1176 |
| GENE | Renal Cysts and Diabetes (RCAD) - HNF-1β sequencing exons 1-9 and dosage analysis by MLPA | 8 weeks | 1176 |
| GENE | Fabry Disease, X-linked - GLA gene sequencing | 4 weeks | 1184 |
| GENE | Androgen Insensitivity - AR gene sequencing | 5 weeks | 1200 |
| GENE | Aniridia, Isolated - PAX6 gene sequencing + deletions/duplications | 5 weeks | 1200 |
| GENE | CADASIL - NOTCH3 gene sequencing | 6 weeks | 1200 |
| GENE | Carrier Screen (Ashkenazi Jewish) - Partnered Report | 4 weeks | 1200 |
| GENE | Carrier Screen (Pan-Ethnic) - Partnered Report | 4 weeks | 1200 |
| GENE | CHARGE Syndrome - CHD7 gene sequencing | 6 weeks | 1200 |
| GENE | Duchenne Muscular Dystrophy - full sequencing DMD1 gene | 6 weeks | 1200 |
| GENE | Familial Mediterranean fever - MEFV gene sequencing | 5 weeks | 1200 |
| GENE | Gaucher Disease full gene sequencing | 6 weeks | 1200 |
| GENE | Hyperparathyroidism - CASR sequencing | 6 weeks | 1200 |
| GENE | Marfan Syndrome - FBN1 sequencing + deletions/duplications | 6 weeks | 1200 |
| GENE | Medium-Chain Acyl-CoA Dehydrogenase Deficiency - ACADM sequencing | 5 weeks | 1200 |
| GENE | Nystagmus, X-linked Infantile - FRMD7 gene sequencing | 6 weeks | 1200 |
| GENE | Pelizaeus-Merzbacher Disease - PLP1 sequencing + deletions/duplications | 6 weeks | 1200 |
| GENE | Pendred Syndrome - SLC26A4 gene sequencing | 6 weeks | 1200 |
| GENE | Peutz-Jegher Syndrome - STK1 sequencing + deletions/duplications | 5 weeks | 1200 |
| GENE | POLG-Related Disorders - full POLG sequencing + deletions and duplications | 6 weeks | 1200 |
| GENE | Retinoblastoma - RB1 sequencing + deletions/duplications | 6 weeks | 1200 |
| GENE | Rett Syndrome (MECP2 gene only) - full sequencing + deletions/duplications | 6 weeks | 1200 |
| GENE | Short-Chain Acyl-CoA Dehydrogenase Deficiency - ACADS sequencing | 6 weeks | 1200 |
| GENE | Short Stature - SHOX variant screening + deletions/duplications | 8 weeks | 1200 |
| GENE | Smith-Lemli-Opitz Syndrome - DHCR7 sequencing | 5 weeks | 1200 |
| GENE | Sotos Syndrome (Cerebral Gigantism) - NSD1 sequencing + deletions/duplications | 6 weeks | 1200 |
| GENE | Very Long-Chain Acyl-CoA Dehydrogenase Deficiency - ACADVl sequencing | 6 weeks | 1200 |
| GENE | Von Hippel-Lindau Syndrome - VHL sequencing + deletions/duplications | 6 weeks | 1200 |
| GENE | Multiple Endocrine Neoplasia Type 1 - full MEN1 sequencing | 6-7 weeks | 1280 |
| GENE | Breast Cancer NGS Panel | 4 weeks | 1360 |
| GENE | Colorectal Cancer NGS Panel | 4 weeks | 1360 |
| GENE | Hereditary Colorectal Cancer NGS Panel | 4 weeks | 1360 |
| GENE | Lynch Syndrome (HNPCC) NGS Panel | 4 weeks | 1360 |
| GENE | Ovarian Cancer NGS Panel | 4 weeks | 1360 |
| GENE | Prostate Cancer NGS Panel | 4 weeks | 1360 |
| GENE | Brugada Syndrome/Long QT Syndrome NGS Panel | 4-6 weeks | 1760 |
| GENE | Cardiomyopathy, Dilated NGS Panel | 6 weeks | 1760 |
| GENE | Cardiomyopathy, Hypertrophic NGS Panel | 6 weeks | 1760 |
| GENE | Dilated Cardiomyopathy NGS Panel | 6 weeks | 1760 |
| GENE | Endometrial Cancer NGS Panel | 4 weeks | 1760 |
| GENE | Epilepsy, Adolescent/Adult Onset Panel | 6 weeks | 1760 |
| GENE | Kidney/Urinary Tract Comprehensive Cancer NGS Panel | 4 weeks | 1760 |
| GENE | Long QT Syndrome/Brugada Syndrome NGS Panel | 4-6 weeks | 1760 |
| GENE | Melanoma Comprehensive Cancer NGS Panel | 4 weeks | 1760 |
| GENE | Nervous System/Brain Cancer NGS Panel | 4 weeks | 1760 |
| GENE | Pancreatic Cancer NGS Panel | 4 weeks | 1760 |
| GENE | Paraganglioma/Pheochromocytoma NGS Panel | 4 weeks | 1760 |
| GENE | Pheochromocytoma/Paraganglioma NGS Panel | 5 weeks | 1760 |
| GENE | Thyroid Cancer NGS Panel | 4 weeks | 1760 |
| GENE | Urinary Tract/Renal Cancer NGS Panel | 4 weeks | 1760 |
| GENE | Cancer, Comprehensive NGS Panel | 5 weeks | 1920 |
| GENE | Cornelia de Lange Syndrome NGS Panel | 6 weeks | 1920 |
| GENE | Familial Hypocalciuric Hypercalcaemia (FHH) Panel | 6-7 weeks | 1920 |
| GENE | Tuberous Sclerosis (TSC1 + TSC2) | 7 weeks | 1920 |
| GENE | Mitochondrial Genome Sequencing | 6 weeks | 1936 |
| GENE | Neurofibromatosis Type 1 - NF1 + SPRED1 sequencing + deletions/duplications | 8 weeks | 1968 |
| GENE | Facioscapulohumeral Muscular Dystrophy (FSHD) - D4Z4 repeat deletion | 9 weeks | 2000 |
| GENE | Hereditary Comprehensive Cancer NGS Panel | 5 weeks | 2000 |
| GENE | Maturity-Onset Diabetes of the Young (MODY) Diabetes NGS Panel | 12 weeks | 2016 |
| GENE | Amyotrophic Lateral Sclerosis (Motor Neurone Disease) NGS Panel | 5 weeks | 2560 |
| GENE | Angelman/Rett Syndromes NGS Panel | 5 weeks | 2560 |
| GENE | Anophthalmia/Microphthalmia/Coloboma NGS Panel | 6 weeks | 2560 |
| GENE | Ataxia NGS Panel | 6 weeks | 2560 |
| GENE | Autoinflammatory/Periodic Fever NGS Panel | 6 weeks | 2560 |
| GENE | Bardet-Biedl Syndrome NGS Panel | 6 weeks | 2560 |
| GENE | Batten Disease (Neuronal Ceroid Lipofuscinosis) NGS Panel | 6 weeks | 2560 |
| GENE | CAKUT (Congenital Anomalies of Kidney & Urinary Tract) NGS Panel | 6 weeks | 2560 |
| GENE | Cardiovascular, Comprehensive NGS Panel | 6 weeks | 2560 |
| GENE | Charcot-Marie-Tooth Syndrome NGS Panel | 6 weeks | 2560 |
| GENE | Cholestasis NGS Panel | 6 weeks | 2560 |
| GENE | Congenital Adrenal Hyperplasia NGS Panel | 6 weeks | 2560 |
| GENE | Congenital Myopathy NGS Panel | 6 weeks | 2560 |
| GENE | Connective Tissue Disorders NGS Panel | 6 weeks | 2560 |
| GENE | Craniosynostosis NGS Panel | 6 weeks | 2560 |
| GENE | Diabetes - Obesity NGS Panel | 6 weeks | 2560 |
| GENE | Ehlers-Danlos Syndrome NGS Panel | 6 weeks | 2560 |
| GENE | Epidermolysis Bullosa NGS Panel | 6 weeks | 2560 |
| GENE | Epilepsy, Comprehensive NGS Panel | 6 weeks | 2560 |
| GENE | Fatty Acid Oxidation Deficiency NGS Panel | 6 weeks | 2560 |
| GENE | Hearing Loss NGS Panel | 6 weeks | 2560 |
| GENE | Hereditary Spastic Paraplegia Comprehensive NGS Panel | 5 weeks | 2560 |
| GENE | Hirschsprung Disease NGS Panel | 6 weeks | 2560 |
| GENE | Hyperinsulinism NGS Panel | 6 weeks | 2560 |
| GENE | Intellectual Disability NGS Panel | 6 weeks | 2560 |
| GENE | Joubert/Meckel-Gruber Syndrome NGS Panel | 6 weeks | 2560 |
| GENE | Kallmann Syndrome NGS Panel | 6 weeks | 2560 |
| GENE | Limb-Girdle Muscular Dystrophy (LGMD) NGS Panel | 6 weeks | 2560 |
| GENE | Lissencephaly NGS Panel | 6 weeks | 2560 |
| GENE | Brugada | 6 weeks | 2560 |
| GENE | Marfan Syndrome and Thoracic Aortic Aneurysm and Dissection NGS Panel | 6 weeks | 2560 |
| GENE | Meckel-Gruber/Joubert Syndrome NGS Panel | 6 weeks | 2560 |
| GENE | Microphthalmia/Anophthalmia/Coloboma NGS Panel | 6 weeks | 2560 |
| GENE | Motor Neurone Disease (Amyotrophic Lateral Sclerosis) NGS Panel | 5 weeks | 2560 |
| GENE | Mucopolysaccharidosis NGS Panel | 6 weeks | 2560 |
| GENE | Nephrotic Syndrome, Steroid-Resistant NS Panel | 6 weeks | 2560 |
| GENE | Neuronal Ceroid Lipofuscinosis (Batten Disease) NGS Panel | 6 weeks | 2560 |
| GENE | Noonan Syndrome and RASopathies NGS Panel | 6 weeks | 2560 |
| GENE | Osteogenesis Imperfecta NGS Panel | 6 weeks | 2560 |
| GENE | Parkinson-Alzheimer-Dementia NGS Panel | 6 weeks | 2560 |
| GENE | Periodic Fever/Autoinflammation NGS Panel | 6 weeks | 2560 |
| GENE | Polycystic Kidney NGS Panel | 6 weeks | 2560 |
| GENE | Posterior Cerebellar Hypoplasia NGS Panel | 6 weeks | 2560 |
| GENE | Primary Ciliary Dyskinesia (PCD) NGS Panel | 6 weeks | 2560 |
| GENE | Primary Hyperoxaluria NGS Panel | 7 weeks | 2560 |
| GENE | Renal/Urinary Tract Cancer NGS Panel | 4 weeks | 2560 |
| GENE | Rett/Angelman Syndromes NGS Panel | 5 weeks | 2560 |
| GENE | Spastic Paraplegia NGS Panel | 6 weeks | 2560 |
| GENE | Spinocerebellar Ataxia NGS Panel | 6 weeks | 2560 |
| GENE | Treacher Collins Syndrome and Related Disorders NGS Panel | 6 weeks | 2560 |
| GENE | Usher Syndrome NGS Panel | 6 weeks | 2560 |
| GENE | Zellweger Syndrome NGS Panel | 6 weeks | 2560 |
| GENE | Skeletal Dysplasia NGS Panel | 6 weeks | 3040 |
| GENE | Whole Genome Sequencing (solo/duo/trio) | 5-8 weeks | 5600 |
| GRP | Azoospermia - karyotype + Y deletions + cystic fibrosis screen (+ polyT(5T) when clinically relevant) | 10-15 days | 1076 |
| GRP | Congenital Absence of Vas Deferens - karyotype + Y deletions + cystic fibrosis screen (+ polyT(5T) when clinically relevant) | 10-15 days | 1076 |
| GRP | Genetic Reproductive Profile (Male) | 10-15 days | 1076 |
| GRP | Male Genetic Reproductive Profile | 10-15 days | 1076 |
| KARY, FISH | 1p36 Deletion Syndrome – karyotype + CGH | 12-17 days | 974 |
| KARY, FISH | Phelan-McDermid Syndrome - karyotype + FISH | 12-17 days | 974 |
| PBOB | Cri du Chat Syndrome - BOBs only | 5 days | 416 |
| PBOB | Langer-Giedion Syndrome - BOBs only | 5 days | 416 |
| PBOB | Microdeletion (common) Syndromes - BOBs only | 5 days | 416 |
| PBOB | Miller-Dieker Syndrome - BOBs only | 5 days | 416 |
| PBOB | Smith-Magenis Syndrome - BOBs only | 5 days | 416 |
| PBOB | Wolf-Hirschhorn Syndrome - BOBs only | 5 days | 416 |
| PBOB, KARY | Cri du Chat Syndrome - BOBs (5 days) + karyotype (15 days) | 5-15 days | 1165 |
| PBOB, KARY | Langer-Giedion Syndrome - BOBs (5 days) + karyotype (15 days) | 5-15 days | 1165 |
| PBOB, KARY | Miller-Dieker Syndrome - BOBs (5 days) + karyotype (15 days) | 5-15 days | 1165 |
| PBOB, KARY | Smith-Magenis Syndrome - BOBs (5 days) + karyotype (15 days) | 5-15 days | 1165 |
| PBOB, KARY | Wolf-Hirschhorn Syndrome - BOBs (5 days) + karyotype (15 days) | 5-15 days | 1165 |
Address20 Old Brompton Road, South Kensington, London SW7 3DL
Email
Phone
